ASPT
ALADDIN SEPARATION TECH
stock OTC

Here are 3 major bioprinting stocks:
Organovo (NASDAQ: ONVO): This is the most well-known bioprinting company, and the first to market its 3D bioprinted liver and kidney tissues for drug toxicity testing. The company has partnerships with major pharmaceutical and cosmetic companies, such as Merck and L’Oréal, and is also developing bioprinted patches for organ repair and regeneration.
CELLINK (NASDAQ: CLNK): This is the leading provider of bioprinters and bioinks, which are the materials used to print living cells. The company offers a range of bioprinters for different applications and budgets, and has a global customer base of over 1,000 academic and industrial institutions. The company also acquires and invests in other bioprinting companies, such as Prellis Biologics and Nanoscribe.
Aspect Biosystems (TSXV: ASPT): This is a Canadian bioprinting company that uses a proprietary microfluidic technology to print complex and functional tissues, such as blood vessels, airways, and cartilage. The company collaborates with academic and industry partners, such as Johnson & Johnson and Merck, to develop bioprinted solutions for various diseases and disorders.

Here are 3 major bioprinting stocks:
Organovo (NASDAQ: ONVO): This is the most well-known bioprinting company, and the first to market its 3D bioprinted liver and kidney tissues for drug toxicity testing. The company has partnerships with major pharmaceutical and cosmetic companies, such as Merck and L’Oréal, and is also developing bioprinted patches for organ repair and regeneration.
CELLINK (NASDAQ: CLNK): This is the leading provider of bioprinters and bioinks, which are the materials used to print living cells. The company offers a range of bioprinters for different applications and budgets, and has a global customer base of over 1,000 academic and industrial institutions. The company also acquires and invests in other bioprinting companies, such as Prellis Biologics and Nanoscribe.
Aspect Biosystems (TSXV: ASPT): This is a Canadian bioprinting company that uses a proprietary microfluidic technology to print complex and functional tissues, such as blood vessels, airways, and cartilage. The company collaborates with academic and industry partners, such as Johnson & Johnson and Merck, to develop bioprinted solutions for various diseases and disorders.